Headline
The latest stories from AHA Today.
HIPAA-covered entities reported 609 breaches of unsecured protected health information in calendar year 2021, 7% fewer than in 2020, the Department of Health and Human Services’ Office for Civil Rights reported in its latest annual report on the issue.
On Feb. 28, the National Library of Medicine will discontinue its Wireless Information System for Emergency Responders, which provides web-based and standalone applications to help emergency responders address hazardous material incidents
Acute care hospitals, physician group practices and Medicare accountable care organizations may apply through May 31 to participate in the Bundled Payments for Care Improvement Advanced Model for two years beginning in January, the Centers for Medicare & Medicaid Services announced.
The nation’s largest retail, payer and tech disruptors once again invested billions of dollars in health care in 2022, continuing to build out their visions to transform the field.
The Food and Drug Administration yesterday issued a report offering recommendations to address the opioid crisis and the role of analgesic oversight in preventing addiction, overdoses and deaths.
Completing the Moderna or Pfizer COVID-19 monovalent vaccine primary series protects children aged 3-5 and 3-4, respectively, against symptomatic SARS-CoV-2 infection for at least four months, according to a study in those ages released yesterday by the Centers for Disease Control and Prevention.
In a report this week, the Department of Health and Human Services’ Office of Inspector General identified 15 drug codes that in third-quarter 2022 met the Centers for Medicare & Medicaid Services’ criteria for substituting a lower Medicare price for certain Part B drugs.
A new blog from the AHA highlights a Centers for Medicare & Medicaid Services report that found that 70% of hospitals are in compliance with both parts of the Hospital Price Transparency Rule, up from 27% in 2021. The CMS data also showed 82% of hospitals are in compliance with at least one…
Medicare should continue to pay average sales price plus 6% for most separately payable Part B drugs, but cap ASP inflation, AHA told the Medicare Payment Advisory Commission in comments submitted today.
In a blog published in Health Affairs, leaders from the Centers for Medicare & Medicaid Services released updated findings on hospital compliance with the Hospital Price Transparency Rule.